UNLIMIT HEALTH

1. UNLIMIT HEALTH 2023-03-09 → present
2. SCI FOUNDATION 2019-01-18 → 2023-03-09

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

HaysMac LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Having reviewed the funding facilities available to the charity together with the expected future cash flows, the trustees have a reasonable expectation that charity has adequate resources to continue its activities for the foreseeable future and consider that there were no material uncertainties over the charity's financial viability. Accordingly, they also continue to adopt the going concern basis in preparing the financial statements.”

Group structure

1. UNLIMIT HEALTH · parent
   1. SCIF Services Limited 100% · England and Wales · dormant

Significant events

• “Unlimit Health launched its new five-year strategy (2023-2028) in February 2023, along with a new name and brand.”
• “Mauritania's praziquantel delivery was delayed to FY25/26 due to global shipping issues in FY24/25.”
• “Conflict in Sudan prevented SCH services delivery in FY24/25.”
• “Support to Burundi was withdrawn due to audit findings and lack of engagement from the MoH regarding financial controls.”
• “Unlimit Health secured funding from the Gates Foundation for a Subnational Strategy and Action Plan for Schistosomiasis and STH (SNAPS).”
• “In March 2025, Uganda and Cote d'Ivoire began roll-out of a new pediatric treatment option for preschool-aged children as part of ADOPT project pilots.”
• “Unlimit Health appointed two Co-Chairs, with one from an endemic country, following the previous Chair's term end.”
• “Unlimit Health received a Silver Award from Investors in People.”
• “Unlimit Health assumed the Co-Chair role of the NTD NGO Network (NNN) strategic review process in 2024, enhancing its profile and governance.”
• “The investment capital growth stagnated due to new tariffs declared by the USA government.”
• “Income from Effective Altruism sources reduced by 13% in 2024/25 due to withdrawal of support from two EA organisations citing GiveWell recommendation withdrawal.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

5

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +89.8%

  £2,685,865 → £5,096,944

• Cash

  -46.6%

  £12,412,940 → £6,626,010

• Net assets

  -13.9%

  £14,060,987 → £12,111,365

• Employees

  +16%

  25 → 29

• Operating profit

  +47.6%

  -£3,842,786 → -£2,013,201

• Profit before tax

  +39.1%

  -£3,203,357 → -£1,949,622

• Wages

  +17.6%

  £1,536,232 → £1,806,453

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers